Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.

[1]  C. Cordon-Cardo,et al.  Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. , 1999, Journal of the National Cancer Institute.

[2]  Kevin Ryan,et al.  The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.

[3]  F. Zindy,et al.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Bisogna,et al.  Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue , 1998, Oncogene.

[5]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[6]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[7]  F. Sigaux,et al.  Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. , 1998, Blood.

[8]  Richard A. Ashmun,et al.  Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.

[9]  D. Haber,et al.  Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.

[10]  M. Iravani,et al.  Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia , 1997, Oncogene.

[11]  Y. Bang,et al.  Alterations of p16INK4A and p15INK4B genes in gastric carcinomas , 1997, Cancer.

[12]  M. Paul,et al.  Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. , 1997, BioTechniques.

[13]  T. Kinoshita,et al.  Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. , 1997, Blood.

[14]  M. Diccianni,et al.  p16INK4 and p15INK4B alterations in primary gynecologic malignancy. , 1997, Gynecologic oncology.

[15]  J. Herman,et al.  Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. , 1997, Cancer research.

[16]  M. Link,et al.  Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. , 1997, Cancer research.

[17]  D. Quelle,et al.  Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[19]  O. Olopade,et al.  Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  M. Bulyk,et al.  Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. , 1996, Cancer research.

[21]  A. Elefanty,et al.  Expression of the tumour suppressor genes p15 and p16 in malignant melanoma , 1996, Melanoma research.

[22]  C. Larsen.  p16INK4a: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression. , 1996, Oncogene.

[23]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[24]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[25]  N. Cross,et al.  Mutational analysis of the p15 and p16 genes in acute leukaemias , 1996, British journal of haematology.

[26]  M. Inganäs,et al.  Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma. , 1996, British Journal of Cancer.

[27]  Y. Xiong,et al.  Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors. , 1996, Oncogene.

[28]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[29]  R. Sutherland,et al.  Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer , 1995, International journal of cancer.

[30]  G. Hannon,et al.  Deletion of the p16 and p15 genes in human bladder tumors. , 1995, Journal of the National Cancer Institute.

[31]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[32]  L. Cannon-Albright,et al.  Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. , 1995, Oncogene.

[33]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[34]  S. Tavtigian,et al.  Complex structure and regulation of the P16 (MTS1) locus. , 1995, Cancer research.

[35]  R. Berger,et al.  A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. , 1995, Oncogene.

[36]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[37]  M. Raffeld,et al.  Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. , 1995, Cancer research.

[38]  G. Hannon,et al.  Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. , 1995, Cancer research.

[39]  P. Borgen,et al.  Analysis of MTS1/CDK4 in female breast carcinomas. , 1995, Cancer letters.

[40]  M. Pagano,et al.  Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. , 1994, Cancer research.

[41]  D. Louis,et al.  Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. , 1994, Cancer research.

[42]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[43]  Peter A. Jones,et al.  P16 gene in uncultured tumours , 1994, Nature.

[44]  D. Sidransky,et al.  Rates of p16 (MTS1) mutations in primary tumors with 9p loss. , 1994, Science.

[45]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[46]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[47]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[48]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .